Clinical Trial Update: Tocilizumab in Chronic Inflammatory CPPD Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tocilizumab for chronic inflammatory calcium pyrophosphate deposition disease is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Calcium Pyrophosphate Deposition Disease

Drugs mentioned

• Actemra (tocilizumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Calcium Pyrophosphate Deposition Disease | Phase 2 | Status: NOT_YET_RECRUITING